We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $4.41B
1-Year Est. Return 26.21%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
10 Year Est. Return
AUM
$379M
AUM Growth
-$32.8M
Cap. Flow
-$52.7M
Cap. Flow %
-13.9%
Top 10 Hldgs %
65.17%
Holding
161
New
8
Increased
29
Reduced
62
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 3.84%
2 Financials 2.84%
3 Healthcare 1.16%
4 Industrials 0.99%
5 Consumer Staples 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OZK icon
101
Bank OZK
OZK
$5.61B
$218K 0.06%
+5,428
New +$195K
UL icon
102
Unilever
UL
$136B
$217K 0.06%
3,699
-1,007
-21% -$59.8K
FISV
103
Fiserv Inc
FISV
$27.9B
$215K 0.06%
1,702
-11,936
-88% -$1.41M
SCHW
104
Charles Schwab
SCHW
$187B
$210K 0.06%
3,710
-26,896
-88% -$1.41M
COR icon
105
Cencora
COR
$61.2B
$208K 0.05%
+1,079
New +$187K
AVGO icon
106
Broadcom
AVGO
$2.04T
$206K 0.05%
+2,380
New +$170K
BX icon
107
Blackstone
BX
$110B
$206K 0.05%
+2,212
New +$191K
APH icon
108
Amphenol
APH
$209B
$202K 0.05%
4,750
-1,438
-23% -$55.9K
NU icon
109
Nu Holdings
NU
$66.9B
$111K 0.03%
14,100
COMP icon
110
Compass
COMP
$9.66B
$53.4K 0.01%
+15,257
New +$50K
BNY
111
Bank of New York Mellon
BNY
$107B
-19,447
Closed -$884K
BKNG icon
112
Booking.com
BKNG
$161B
-7,050
Closed -$748K
BKR icon
113
Baker Hughes
BKR
$61.1B
-14,100
Closed -$407K
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$12.4B
-5,000
Closed -$486K
BMY icon
115
Bristol-Myers Squibb
BMY
$132B
-9,682
Closed -$671K
BUD icon
116
AB InBev
BUD
$165B
-10,200
Closed -$681K
CARR icon
117
Carrier Global
CARR
$52.8B
-10,454
Closed -$478K
CE icon
118
Celanese
CE
$4.82B
-3,967
Closed -$432K
CHTR icon
119
Charter Communications
CHTR
$18.2B
-2,756
Closed -$986K
CI icon
120
Cigna
CI
$74.6B
-1,918
Closed -$490K
CMCSA icon
121
Comcast
CMCSA
$90B
-36,135
Closed -$1.37M
COHR icon
122
Coherent
COHR
$74.2B
-10,700
Closed -$407K
COP icon
123
ConocoPhillips
COP
$141B
-8,104
Closed -$804K
CVS icon
124
CVS Health
CVS
$122B
-12,871
Closed -$956K
DELL icon
125
Dell
DELL
$293B
-6,500
Closed -$261K

Similar funds

Callan Family Office's Q2 2023 Portfolio in Review

As of Q2 2023, Callan Family Office held 161 positions worth $379M, down 8% from $412M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Callan Family Office withdrew a net $52.7M in Q2 2023, closing 51 positions and reducing 62 holdings. Its most notable exit was Occidental Petroleum, an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 5.2% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Callan Family Office opened a new position in Vanguard Morningstar Small-Cap ETF worth $231K.

  • Callan Family Office's largest Q2 2023 buy was Vanguard Morningstar Small-Cap ETF: 1,159 shares worth $231K.
  • Callan Family Office added most to iShares Core MSCI EAFE ETF in Q2 2023, an estimated $1M increase.
  • Callan Family Office's biggest Q2 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $2.88M.
  • Callan Family Office fully exited Occidental Petroleum in Q2 2023, selling an estimated $1.6M.
  • Callan Family Office's ten largest holdings make up 65% of its $379M portfolio in Q2 2023.
  • Callan Family Office opened 8 new positions and closed 51 in Q2 2023.
  • Callan Family Office's portfolio value fell 8% quarter-over-quarter to $379M.

Based on Callan Family Office's 13F filing for Q2 2023, filed 14 Aug 2023.